Walgreens Boots Alliance (NASDAQ:WBA) Trading 2% Higher (2024)

Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) shares traded up 2% during mid-day trading on Tuesday . The stock traded as high as $15.57 and last traded at $15.45. 3,003,568 shares changed hands during trading, a decline of 77% from the average session volume of 12,934,575 shares. The stock had previously closed at $15.15.

Wall Street Analyst Weigh In

• Here's Why Analysts Boosted Walmart Stock's Valuation

Several analysts recently commented on the company. Raymond James reaffirmed a "market perform" rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an "underweight" rating for the company in a research report on Friday, May 31st. Evercore ISI reduced their target price on Walgreens Boots Alliance from $18.00 to $17.00 and set an "in-line" rating on the stock in a report on Monday, June 3rd. Leerink Partnrs reissued a "market perform" rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Finally, Truist Financial reaffirmed a "hold" rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $23.57.

Get Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Stock Up 5.5 %

• Top 3 Bargain Stocks to Watch Near Their 52-Week Low Prices

The business has a fifty day moving average price of $17.02 and a two-hundred day moving average price of $20.60. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The firm has a market capitalization of $13.79 billion, a price-to-earnings ratio of -2.29, a price-to-earnings-growth ratio of 0.97 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same period in the previous year, the business earned $1.16 EPS. Walgreens Boots Alliance's quarterly revenue was up 6.3% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

• CVS Health Stock Has a Silver Lining Called Value

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a dividend of $0.25 per share. The ex-dividend date was Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 6.25%. Walgreens Boots Alliance's dividend payout ratio is presently -14.29%.

Insider Activity

In related news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares of the company's stock, valued at $3,235,859.22. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Manmohan Mahajan purchased 6,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares of the company's stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company's stock.

Hedge Funds Weigh In On Walgreens Boots Alliance

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Fulton Bank N.A. grew its stake in Walgreens Boots Alliance by 0.5% during the 4th quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator's stock worth $2,796,000 after buying an additional 523 shares during the last quarter. Insight Folios Inc boosted its position in shares of Walgreens Boots Alliance by 5.8% during the 4th quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator's stock worth $252,000 after purchasing an additional 525 shares in the last quarter. Atlas Brown Inc. grew its stake in shares of Walgreens Boots Alliance by 1.8% during the 1st quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator's stock worth $685,000 after purchasing an additional 550 shares during the period. Pinnacle Financial Partners Inc increased its holdings in shares of Walgreens Boots Alliance by 4.9% in the 4th quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator's stock valued at $310,000 after purchasing an additional 555 shares in the last quarter. Finally, Westpac Banking Corp lifted its stake in shares of Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator's stock valued at $159,000 after purchasing an additional 560 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

• Five stocks we like better than Walgreens Boots Alliance
• Occidental Stock: Buffett's 9-Day Buying Spree Lifts Stake to 29%
• Manufacturing Stocks Investing
• 3M Stock: Invest Now for Unmatched Quality and Growth Potential
• What does consumer price index measure?
• Super Micro AI Stock: Should You Invest After a 275% Increase?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here